The New IASLC/ATS/ERS Lung Adenocarcinoma Classification

FYI-Excellent content for CME 
 
In 2011, the Journal for Thoracic Oncology published the "International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma," issued by a multidisciplinary team of lung cancer specialists.
 
To better understand the general implications of this new classification, and the issues affecting specific specialties, please join us in this series of webinars.


IASLC Experts Discuss Events
That Are Changing Clinical Practice

 
Module 1 - Introducing The New IASLC/ATS/ERS Lung Adenocarcinoma Classification
William D. Travis, MD
Memorial Sloan Kettering Cancer Center - NY, NY

Module 2 - Implications of the New IASLC/ATS/ERS Classification
Fred R. Hirsch, MD, PhD
University of Colorado Cancer Center - Aurora, CO
Paul Van Schil, MD, PhD
University Hospital of Antwerp - Edegem (Antwerp), Belgium
 
Module 3 - Highlights for the Pathologist
Ming S. Tsao, MD, FRCPC

Princess Margaret Hospital - Toronto, Ontario, Canada
 
Module 4 - Highlights for the Radiologist
Kavita Garg, MD
University of Colorado Cancer Center - Aurora, CO
 
Module 5 - Case Studies for the Practicing Clinician
Gregory Riely, MD, PhD
Memorial Sloan Kettering Cancer Center - NY, NY













This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the International Association for the Study of Lung Cancer (IASLC) and the University of Colorado School of Medicine. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

                       This activity is supported in part, by an educational grant from Eli Lilly and Company










 



Forward this email

This email was sent to mdpool@me.com by iaslc@clinicalinsights.net |  

Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy.

Clinical Insights, Inc. | 39 Broadway | Suite 540 | New York | NY | 10006